Histone H2A.X Antibody

What is Histone H2A.X and why is it important as a research target?

Histone H2A.X is a variant histone that replaces conventional H2A in a subset of nucleosomes. This 143-amino acid protein plays central roles in:

• Transcription regulation

• DNA repair mechanisms

• DNA replication

• Chromosomal stability

• Nervous system development

H2A.X is critical for checkpoint-mediated arrest of cell cycle progression in response to low doses of ionizing radiation and for efficient repair of DNA double-strand breaks (DSBs), particularly when modified by C-terminal phosphorylation . It represents approximately 10% of the total H2A histone proteins in normal human fibroblasts .

What are the key post-translational modifications of H2A.X and their significance?

The primary post-translational modifications of H2A.X include:

Phosphorylation at Ser139 (forming γ-H2AX) is the most extensively studied modification, serving as a sensitive biomarker for DNA damage and a platform for repair protein recruitment .

What are the common applications for Histone H2A.X antibodies in research?

Histone H2A.X antibodies are utilized in multiple experimental contexts:

These applications enable researchers to investigate H2A.X dynamics across diverse experimental systems from cell lines to tissue samples .

How should researchers optimize protein extraction for detecting chromatin-bound H2A.X in Western blotting?

Standard protein extraction methods may be insufficient for chromatin-bound proteins like H2A.X. For optimal results:

• Use a high salt/sonication protocol for nuclear extracts when preparing samples for Western blot .

• Include nuclease treatment (e.g., benzonase at 1:2000 dilution) in lysis buffer to recover chromatin-bound material that would otherwise be lost during clarification .

• For total H2A.X detection, observed molecular weight typically ranges from 15-18 kDa , while phosphorylated H2A.X (Ser139) may appear at approximately 17 kDa .

• When analyzing phosphorylated H2A.X, positive controls such as cells treated with UV radiation (20 mJ/cm²) or camptothecin (1 μM) are recommended .

Several researchers note that without appropriate extraction methods, chromatin-bound proteins like H2A.X frequently fractionate to the pellet rather than appearing in low-salt nuclear extracts .

What are the key considerations for optimizing immunocytochemistry and immunofluorescence protocols using H2A.X antibodies?

For robust immunofluorescence results with H2A.X antibodies:

• Fixation and Permeabilization:

  • Standard formaldehyde fixation (3-4%) is generally effective

  • For intracellular staining in flow cytometry, fixing with specific fixation buffers followed by permeabilization with 90% methanol is recommended

• Antigen Retrieval:

  • For tissue sections, epitope exposure with citrate buffer (pH 6.0) or TE buffer (pH 9.0) significantly enhances staining quality

  • This step is particularly important for formalin-fixed paraffin-embedded (FFPE) samples

• Antibody Dilutions:

  • For phospho-H2A.X (Ser139): 1:400-1:1600 for immunofluorescence

  • For total H2A.X: 1:1000-1:4000 for immunofluorescence/ICC

• Nuclear Counterstaining:

  • DAPI is commonly used to visualize nuclei in conjunction with H2A.X staining

  • This aids in confirming nuclear localization of the H2A.X signal

For optimal visualization of γ-H2AX foci formation following DNA damage, researchers typically use fluorescent secondary antibodies such as Northern-Lights™ 557-conjugated Anti-Mouse IgG or Alexa Fluor conjugates .

How do different H2A.X antibodies compare in terms of specificity and cross-reactivity?

When selecting an H2A.X antibody, researchers should consider species reactivity and specificity profiles:

For phospho-specific antibodies, specificity can be verified by:

• Comparing treated vs. untreated samples (e.g., UV radiation, camptothecin)

• Using phosphatase treatment as a negative control

• Confirming the absence of signal in H2A.X knockout models

Researchers should note that some antibodies may detect unexpected band sizes due to post-translational modifications, with phosphorylated H2A.X sometimes appearing at approximately 30 kDa in Simple Western analyses rather than the expected 15-17 kDa .

How can γ-H2AX be effectively used as a biomarker in clinical research and drug development studies?

γ-H2AX has emerged as a valuable biomarker in clinical research settings:

• Radiation Biology and Biodosimetry:

  • γ-H2AX foci formation correlates with radiation dose and can serve as a biodosimeter for radiation exposure assessment

  • The temporal dynamics of foci formation and resolution provide insights into DNA repair efficiency

• Drug Development and Evaluation:

  • Can evaluate the efficiency of DNA-damaging agents in vivo

  • Helps assess patient responses to specific chemotherapeutic regimens

  • Allows for personalized treatment optimization based on individual DNA damage responses

• Clinical Diagnostics:

  • Aids in diagnosing syndromes associated with elevated γ-H2AX levels

  • Holds potential for monitoring disease progression and treatment efficacy

For quantitative assessment, researchers should establish standardized protocols for sample collection, processing, and image analysis to ensure reproducibility across clinical studies .

What controls should be included when using H2A.X antibodies in ChIP and ChIP-Seq experiments?

For robust ChIP and ChIP-Seq experiments with H2A.X antibodies:

• Input Controls:

  • Reserve a portion (5-10%) of sonicated chromatin before immunoprecipitation

  • Use for normalization during data analysis

• Negative Controls:

  • IgG from the same species as the H2A.X antibody

  • No-antibody controls to assess non-specific binding

• Positive Controls:

  • Known H2A.X-enriched regions (for total H2A.X)

  • For phospho-H2A.X (Ser139), include samples treated with DNA-damaging agents

• Validation Methods:

  • Confirm specificity with Western blot prior to ChIP experiments

  • For ChIP-validated antibodies, recommended dilutions range from 1:10 to 1:100

HeLa nuclear extract can serve as a reliable positive control specifically for phospho-H2A.X (Ser139) antibodies in these applications .

How do different fixation and sample preparation methods affect H2A.X detection in complex tissues?

Tissue fixation and preparation significantly impact H2A.X antibody performance:

• FFPE Tissues:

  • Require antigen retrieval with citrate buffer (pH 6.0) or TE buffer (pH 9.0)

  • Phospho-epitopes may be partially masked by formalin fixation

  • Specialized ChIP protocols (e.g., ChIP-IT® FFPE) are required for chromatin studies

• Frozen Tissues:

  • Generally provide better epitope preservation

  • Require careful optimization of fixation time to maintain tissue architecture while preserving antigenicity

  • Appropriate for multiple applications including IHC, IF, and ChIP

• Cell Preparation for Flow Cytometry:

  • Fixation with specific flow cytometry fixation buffers

  • Permeabilization with 90% methanol for intracellular phospho-H2A.X detection

  • Use of appropriate blocking reagents to minimize background

For challenging samples like peripheral blood mononuclear cells (PBMCs), specialized protocols like ChIP-IT® PBMC are recommended to ensure reproducible results .

What are the best quantification methods for analyzing γ-H2AX foci in response to DNA damage?

Quantitative analysis of γ-H2AX foci requires robust methodologies:

• Microscopy-Based Analysis:

  • Confocal microscopy with z-stacking to capture foci throughout the nuclear volume

  • Automated image analysis software to count foci number, size, and intensity

  • Minimum of 50-100 nuclei should be analyzed per condition for statistical validity

• Flow Cytometry Quantification:

  • Measures total γ-H2AX signal intensity rather than individual foci

  • Enables rapid analysis of thousands of cells

  • Particularly useful for heterogeneous populations

  • Example protocol: After treatment (e.g., 1 μM camptothecin overnight), fix cells, permeabilize with 90% methanol, and stain with phospho-H2A.X (Ser139) antibodies followed by fluorophore-conjugated secondary antibodies

• Western Blot Densitometry:

  • Provides population-average measurement of γ-H2AX levels

  • Should be normalized to total H2A.X or other loading controls

  • Less sensitive than microscopy or flow cytometry for detecting subtle changes

Time-course experiments (typically 0.5, 1, 2, 4, 8, and 24 hours post-treatment) are recommended to capture both the formation and resolution phases of γ-H2AX foci, providing insights into DNA repair kinetics.

How can researchers address non-specific binding and background issues when using H2A.X antibodies?

Non-specific binding can compromise H2A.X antibody experiments. Key mitigation strategies include:

• Antibody Selection and Validation:

  • Use antibodies validated for specific applications (WB, IF, IHC, ChIP)

  • Review published validation data showing specificity across applications

• Optimization of Blocking Conditions:

  • Test different blocking reagents (BSA, normal serum, commercial blockers)

  • Extend blocking time to 1-2 hours at room temperature or overnight at 4°C

• Application-Specific Adjustments:

  • For Western blotting: Optimize antibody dilution (typically 1:1000-1:4000)

  • For immunofluorescence: Include additional washing steps and use directly conjugated antibodies where possible

  • For ChIP: Increase pre-clearing steps with protein A/G beads

• Negative Controls:

  • Include antibody-omission controls

  • Use isotype controls from the same species

  • For phospho-specific antibodies, include dephosphorylated samples

Researchers should calibrate antibody concentrations carefully, as both insufficient and excessive antibody amounts can contribute to background issues.

What strategies can be employed when γ-H2AX signal is weak or undetectable despite appropriate treatments?

When γ-H2AX signal is unexpectedly weak or absent:

• Sample Preparation Issues:

  • Ensure chromatin-bound proteins are effectively extracted using high salt/sonication protocols

  • Include nuclease treatment (e.g., benzonase) to recover chromatin-bound material

  • Verify that fixation conditions preserve phospho-epitopes

• Timing Considerations:

  • Confirm appropriate timing post-treatment (peak γ-H2AX typically occurs 30 minutes to 1 hour after DNA damage)

  • Consider that some cell types show delayed or reduced γ-H2AX formation

• Technical Adjustments:

  • Try antigen retrieval with citrate buffer (pH 6.0) or TE buffer (pH 9.0)

  • For Western blotting, transfer conditions may need optimization for small proteins (15-18 kDa)

  • In fluorescence microscopy, adjust exposure settings and use high-sensitivity cameras

• Alternative Detection Methods:

  • If one application fails (e.g., Western blot), try another (e.g., flow cytometry or immunofluorescence)

  • Consider amplification systems like tyramide signal amplification for very low signals

Fresh phosphatase inhibitors in all buffers are essential when detecting phosphorylated H2A.X to prevent epitope loss during sample processing.

How are H2A.X antibodies being utilized in single-cell analyses and advanced imaging techniques?

H2A.X antibodies are increasingly integrated into cutting-edge single-cell and advanced imaging approaches:

• Single-Cell Techniques:

  • Flow cytometry enables γ-H2AX quantification at the single-cell level, revealing population heterogeneity in DNA damage responses

  • Mass cytometry (CyTOF) can combine γ-H2AX detection with dozens of other cellular markers

  • Single-cell sequencing approaches may integrate with CUT&Tag or CUT&RUN methodologies for epigenomic profiling

• Super-Resolution Microscopy:

  • Techniques like STORM and PALM provide nanoscale visualization of γ-H2AX foci structure

  • Enable co-localization studies with other DNA repair factors at unprecedented resolution

  • Require high-quality, directly conjugated antibodies (e.g., Alexa Fluor conjugates)

• Live-Cell Imaging:

  • Fluorescent protein fusions to H2A.X enable real-time monitoring of foci dynamics

  • Complementary to fixed-cell antibody-based approaches for validation

These advanced applications typically require extensive optimization and specialized equipment, but provide unique insights into H2A.X biology that are unattainable with traditional methods.

What is the current understanding of alternative H2A.X modifications beyond Ser139 phosphorylation?

While phosphorylation at Ser139 (γ-H2AX) is the most studied modification, research has revealed other important H2A.X modifications:

Researchers investigating these modifications should consider:

• Using antibodies specific to individual modifications

• Employing mass spectrometry for comprehensive post-translational modification mapping

• Implementing co-immunoprecipitation approaches to study interactions between differently modified H2A.X populations

The interplay between multiple modifications creates a complex regulatory network that influences DNA damage response outcomes beyond what can be revealed by studying γ-H2AX alone .

How can researchers effectively validate and benchmark new H2A.X antibodies against established standards?

Systematic validation of new H2A.X antibodies ensures experimental reliability:

• Comparison Testing:

  • Benchmark against widely cited antibodies with established performance

  • Test multiple antibodies in parallel across applications

  • Compare monoclonal vs. polyclonal options for specific experimental needs

• Multi-Application Validation:

  • Verify performance across Western blot, immunofluorescence, and flow cytometry

  • Confirm consistent results between applications

  • For phospho-specific antibodies, use treated/untreated samples as specificity controls

• Species Cross-Reactivity:

  • Validate separately for each species despite predicted cross-reactivity

  • Consider sequence differences at epitope regions

  • Note that H2A.X is highly conserved (100% identity) across many mammalian species

• Documentation and Reporting:

  • Record detailed validation protocols and results

  • Share validation data with the research community

  • Consider antibody reporting standards like those from the International Working Group for Antibody Validation

Thorough validation is particularly important for antibodies used in clinical research applications, where standardization and reproducibility are essential .